Clinical trial
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
NCT00375973 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00375973 |
|---|---|
| Title | Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome |
| Official title | A Randomized, Placebo-Controlled, Double-Blind Trial of Duloxetine in the Treatment of Patients With Chronic Fatigue Syndrome |
| Acronym | CFS |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Fatigue Syndrome, Chronic |
| Intervention type | Drug |
| Interventions | Duloxetine, Placebo |
| Enrollment | 60 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2012 |
| Completion | Mar 1, 2014 |
| First posted | Sep 13, 2006 |
| Last update posted | Aug 21, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: